Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Fmoc-N-methyl-L-phenylalanine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

77128-73-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 77128-73-5 Structure
  • Basic information

    1. Product Name: Fmoc-N-methyl-L-phenylalanine
    2. Synonyms: FMOC-N-METHYL-L-PHENYLALANINE;FMOC-N-ME-L-PHE-OH;FMOC-N-ME-PHENYLALANINE;FMOC-N-ME-PHE-OH;FMOC-N-ALPHA-METHYL-L-PHENYLALANINE;FMOC-MEPHE-OH;FMOC-L-MEPHE-OH;N-ALPHA-FMOC-N-ALPHA-METHYL-L-PHENYLALANINE
    3. CAS NO:77128-73-5
    4. Molecular Formula: C25H23NO4
    5. Molecular Weight: 401.45
    6. EINECS: N/A
    7. Product Categories: Amino Acids;N-Methyl Amino Acids
    8. Mol File: 77128-73-5.mol
  • Chemical Properties

    1. Melting Point: 132.0 to 136.0 °C
    2. Boiling Point: 595.4 °C at 760 mmHg
    3. Flash Point: 313.9 °C
    4. Appearance: Off-white/Powder
    5. Density: 1.26 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: Soluble in DMF. (0.3gram in 2ml)
    9. PKA: 3.78±0.10(Predicted)
    10. BRN: 4768138
    11. CAS DataBase Reference: Fmoc-N-methyl-L-phenylalanine(CAS DataBase Reference)
    12. NIST Chemistry Reference: Fmoc-N-methyl-L-phenylalanine(77128-73-5)
    13. EPA Substance Registry System: Fmoc-N-methyl-L-phenylalanine(77128-73-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 22-24/25
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 77128-73-5(Hazardous Substances Data)

77128-73-5 Usage

Chemical Properties

White to off-white powder

Uses

N-Fmoc-N-methyl-L-phenylalanine is used in agrochemical, pharmaceutical and dyestuff field.

Check Digit Verification of cas no

The CAS Registry Mumber 77128-73-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,1,2 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 77128-73:
(7*7)+(6*7)+(5*1)+(4*2)+(3*8)+(2*7)+(1*3)=145
145 % 10 = 5
So 77128-73-5 is a valid CAS Registry Number.

77128-73-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H66565)  N-Fmoc-N-methyl-L-phenylalanine, 95%   

  • 77128-73-5

  • 1g

  • 491.0CNY

  • Detail
  • Alfa Aesar

  • (H66565)  N-Fmoc-N-methyl-L-phenylalanine, 95%   

  • 77128-73-5

  • 5g

  • 1960.0CNY

  • Detail
  • Aldrich

  • (47598)  Fmoc-N-Me-Phe-OH  ≥99.0% (sum of enantiomers, HPLC)

  • 77128-73-5

  • 47598-1G-F

  • 1,395.81CNY

  • Detail

77128-73-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Fmoc-N-methyl-L-phenylalanine

1.2 Other means of identification

Product number -
Other names FMOC-N-ME-PHE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77128-73-5 SDS

77128-73-5Relevant articles and documents

Isostearyl Mixed Anhydrides for the Preparation of N-Methylated Peptides Using C-Terminally Unprotected N-Methylamino Acids

Cary, Douglas R.,Handa, Michiharu,Kobayashi, Yutaka,Kurasaki, Haruaki,Masuya, Keiichi,Matsuda, Ayumu,Matsumoto, Masatoshi,Morimoto, Koki,Nagaya, Akihiro,Nishizawa, Naoki,Taguri, Tomonori,Takeuchi, Hisayuki

, p. 8039 - 8043 (2020/11/02)

Sustainable and efficient manufacturing methods for N-methylated peptides remain underexplored despite growing interest in therapeutic N-methylated peptides within the pharmaceutical industry. A methodology for the coupling of C-terminally unprotected N-methylamino acids mediated by an isostearic acid halide (ISTAX) and silylating reagent has been developed. This approach allows for the coupling of a wide variety of amino acids and peptides in high yields under mild conditions without the need for a C-terminal deprotection step in the process of C-terminal elongation. These advantages make this a useful synthetic method for the production of peptide therapeutics and diagnostics containing N-methylamino acids.

Iridium-Catalyzed Asymmetric Hydrogenation of N-Alkyl α-Aryl Furan-Containing Imines: an Efficient Route to Unnatural N-Alkyl Arylalanines and Related Derivatives

Mazuela, Javier,Antonsson, Thomas,Knerr, Laurent,Marsden, Stephen P.,Munday, Rachel H.,Johansson, Magnus J.

supporting information, p. 578 - 584 (2018/12/11)

High throughput experimentation (HTE) has enabled the rapid identification of ligand/precatalyst combinations that facilitate highly enantioselective hydrogenations of prochiral N-alkyl α-aryl ketimines containing a furyl moiety. The chiral amines obtained have proven to be modular precursors in the synthesis of unnatural mono N-alkylated arylalanines and related derivatives. (Figure presented.).

Investigation for the cyclization efficiency of linear tetrapeptides: Synthesis of tentoxin B and dihydrotentoxin

Sato, Ryota,Oyama, Kie,Konno, Hiroyuki

supporting information, p. 6173 - 6181 (2018/09/17)

Investigation of the cyclization efficiency of N-methyl linear tetrapeptides using a molecular modeling study and chemical synthesis is described. The linear peptide with two N-methyl groups, MeAla-Leu-MePhe-Gly, forms γ-turn like conformation with the am

A new GLP-1 analogue with prolonged glucose-lowering activity in vivo via backbone-based modification at the N-terminus

Bai, Xiaohui,Niu, Youhong,Zhu, Jingjing,Yang, An-Qi,Wu, Yan-Fen,Ye, Xin-Shan

, p. 1163 - 1170 (2016/03/01)

Glucagon-like peptide-1 (GLP-1) is an endogenous insulinotropic hormone with wonderful glucose-lowering activity. However, its clinical use in type II diabetes is limited due to its rapid degradation at the N-terminus by dipeptidyl peptidase IV (DPP-IV). Among the N-terminal modifications of GLP-1, backbone-based modification was rarely reported. Herein, we employed two backbone-based strategies to modify the N-terminus of tGLP-1. Firstly, the amide N-methylated analogues 2-6 were designed and synthesized to make a full screening of the N-terminal amide bonds, and the loss of GLP-1 receptor (GLP-1R) activation indicated the importance of amide H-bonds. Secondly, with retaining the N-terminal amide H-bonds, the β-peptide replacement strategy was used and analogues 7-13 were synthesized. By two rounds of screening, analogue 10 was identified. Analogue 10 greatly improved the DPP-IV resistance with maintaining good GLP-1R activation in vitro, and showed approximately a 4-fold prolonged blood glucose-lowering activity in vivo in comparison with tGLP-1. This modification strategy will benefit the development of GLP-1-based anti-diabetic drugs.

A total synthesis of a highly N-methylated cyclodepsipeptide [2S,3S-Hmp]-aureobasidin L using solid-phase methods

Maharani, Rani,Brownlee, Robert T.C.,Hughes, Andrew B.,Abbott, Belinda M.

, p. 2351 - 2358 (2014/04/03)

[2S,3S-Hmp]-Aureobasidin L 2 has been successfully synthesised through a combination of solution- and solid-phase peptide synthesis. All of the Fmoc-protected residues including a depsidipeptide, Fmoc-MeVal-Hmp-OH, were prepared in solution phase. Chain e

Fluorenylmethoxycarbonyl-N-methylamino acids synthesized in a flow tube-in-tube reactor with a liquid-liquid semipermeable membrane

Buba, Annette E.,Koch, Stefan,Kunz, Horst,Loewe, Holger

supporting information, p. 4509 - 4513 (2013/07/26)

Both steps of the N-methylation of 9-fluorenylmethoxycarbonyl (Fmoc) amino acids were carried out in a microstructured tube-in-tube reactor equipped with a semipermeable Teflon AF 2400 membrane as the inner tubing. In the first step, gaseous formaldehyde

Enantioselective total synthesis of eudistomidins G, H, and I

Ishiyama, Haruaki,Yoshizawa, Kazuaki,Kobayashi, Jun'ichi

experimental part, p. 6186 - 6192 (2012/08/27)

Asymmetric first total synthesis of eudistomidins G, H, and I, tetrahydro-β-carboline alkaloids from the Okinawan marine tunicate Eudistoma glaucus, has been accomplished with the Bischler-Napieralski reaction and the Noyori catalytic asymmetric hydrogen-transfer reaction. The absolute configurations of eudistomidins G, H, and I were confirmed from comparison of the 1H and 13C NMR, and CD spectral data of synthetic and natural eudistomidins G, H, and I, respectively.

Chemical models of peptide formation in translation

Watts, R.Edward,Forster, Anthony C.

experimental part, p. 2177 - 2185 (2011/02/25)

Ribosomal incorporations of N-alkyl amino acids including proline are slower than incorporations of non-N-alkyl L-amino acids. The chemical reactivity hypothesis proposes that these results and the exclusion of nonproline N-alkyl amino acids from the gene

An efficient preparation of N-Methyl-α-amino acids from N-Nosyl-α-amino acid phenacyl esters

Leggio, Antonella,Belsito, Emilia Lucia,De Marco, Rosaria,Liguori, Angelo,Perri, Francesca,Viscomi, Maria Caterina

supporting information; experimental part, p. 1386 - 1392 (2010/06/11)

Chemical Equation Presented In this paper we describe a simple and efficient solution-phase synthesis of N-methyl-TV-nosyl-α-amino acids and N-Fmoc-N-methyl-α-amino acids. This represents a very important application in peptide synthesis to obtain N-methylated peptides in both solution and solid phase. The developed methodology involves the use of N-nosyl-α-amino acids with the carboxyl function protected as a phenacyl ester and the methylating reagent diazomethane. An important aspect of this synthetic strategy is the possibility to selectively deprotect the carboxyl function or alternatively both amino and carboxyl moieties by using the same reagent with a different molar excess and under mild conditions. Furthermore, the adopted procedure keeps unchanged the acid-sensitive side chain protecting groups used in Fmoc-based synthetic strategies.

Improving oral bioavailability of peptides by multiple N-methylation: Somatostatin analogues

Biron, Eric,Chatterjee, Jayanta,Ovadia, Oded,Langenegger, Daniel,Brueggen, Joseph,Hoyer, Daniel,Schmid, Herbert A.,Jelinek, Raz,Gilon, Chaim,Hoffman, Amnon,Kessler, Horst

, p. 2595 - 2599 (2008/12/23)

Full methyl jacket? A complete library of the N-methylated somatostatin cyclopeptidic analogue Veber-Hirschmann peptide cyclo(-PFwKTF-) has been prepared with the aim of improving its bioavailability. Several analogues from the library were found to bind

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 77128-73-5